Guo Zong-Sheng
UPMC Hillman Cancer Center and Departments of Surgery, Microbiology and Molecular Genetics, University of Pittsburgh School of Medicine, Pittsburgh, PA 15213, USA.
Biomedicines. 2021 Jun 10;9(6):663. doi: 10.3390/biomedicines9060663.
Cancer immunotherapy has recently become the most promising strategy for hard-to-treat, advanced-stage malignancies [...].
癌症免疫疗法最近已成为治疗难治性晚期恶性肿瘤最有前景的策略[……]。